Evidence map›Paper›PMID 37889531›Full record

ArticleJournal of medical Internet research2023

Mobilizing Patient and Public Involvement in the Development of Real-World Digital Technology Solutions: Tutorial.

Alison Keogh, Ríona Mc Ardle, Mara Gabriela Diaconu, Nadir Ammour, Valdo Arnera, Federica Balzani, Gavin Brittain, Ellen Buckley, Sara Buttery, Alma Cantu and 20 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Beyond the dataset: integrating public voices in data science.Research involvement and engagement · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Public and participant involvement as a pathway to inclusive dementia research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Alison KeoghInsight Centre Data Analytics, University College Dublin, Dublin4, Ireland.ORCID 0000-0001-5917-6308
Ríona Mc ArdleTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.ORCID 0000-0001-7959-3563
Mara Gabriela DiaconuDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-1482-8306
Nadir AmmourClinical Science and Operations, Global Development, Sanofi Research & Development, Chilly-Mazarin, France.ORCID 0009-0005-3046-5057
Valdo ArneraClario, Clario Holdings Inc, Geneva, Switzerland.ORCID 0000-0002-7920-8669
Federica BalzaniMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Gavin BrittainDepartment of Clinical Neurology, Sheffield Teaching Hospitals National Health Service, Foundation Trust, Sheffield, United Kingdom.ORCID 0000-0002-9903-7203
Ellen BuckleyDepartment of Mechanical Engineering, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-0968-6286
Sara ButteryNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0001-9410-414X
Alma CantuSchool of Computer Science, Newcastle University, Newcastle, United Kingdom.ORCID 0000-0001-6081-2439
Solange Corriol-RohouAstraZeneca Research and Development, Global Regulatory Excellence, Paris, France.ORCID 0000-0002-5227-2724
Laura Delgado-OrtizNon-Communicable Diseases and Environment Programme, ISGlobal, Barcelona, Spain.ORCID 0000-0003-0311-7661
Jacques DuysensMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.ORCID 0000-0002-0043-8817
Tom Forman-HardyMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Tova Gur-AriehMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.ORCID 0000-0002-7419-1968
Dominique HamerlijnckMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.ORCID 0000-0001-8464-0547
John LinnellMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.ORCID 0000-0002-7748-0423
Letizia LeocaniDepartment of Neurology, San Raffele University, Milan, Italy.ORCID 0000-0001-9326-6753
Tom McQuillanMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Isabel NeatrourTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.ORCID 0000-0001-5478-3053
Ashley PolhemusEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-5056-5785
Werner RemmeleMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Isabel SaraivaMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.ORCID 0009-0001-2836-4143
Kirsty ScottDepartment of Mechanical Engineering, University of Sheffield, Sheffield, United Kingdom.ORCID 0009-0007-7931-1424
Norman SuttonMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Koen van den BrandeMobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.
Beatrix VereijkenDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-2231-8138
Martin WohlrabDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.ORCID 0009-0003-2914-4550
Lynn RochesterTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.ORCID 0000-0001-5774-9272
Mobilise-D consortium *See Acknowledgments, .

Funding

Department of Health 301677Wellcome Trust
6 · The paper itself

Abstract

Although the value of patient and public involvement and engagement (PPIE) activities in the development of new interventions and tools is well known, little guidance exists on how to perform these activities in a meaningful way. This is particularly true within large research consortia that target multiple objectives, include multiple patient groups, and work across many countries. Without clear guidance, there is a risk that PPIE may not capture patient opinions and needs correctly, thereby reducing the usefulness and effectiveness of new tools. Mobilise-D is an example of a large research consortium that aims to develop new digital outcome measures for real-world walking in 4 patient cohorts. Mobility is an important indicator of physical health. As such, there is potential clinical value in being able to accurately measure a person's mobility in their daily life environment to help researchers and clinicians better track changes and patterns in a person's daily life and activities. To achieve this, there is a need to create new ways of measuring walking. Recent advancements in digital technology help researchers meet this need. However, before any new measure can be used, researchers, health care professionals, and regulators need to know that the digital method is accurate and both accepted by and produces meaningful outcomes for patients and clinicians. Therefore, this paper outlines how PPIE structures were developed in the Mobilise-D consortium, providing details about the steps taken to implement PPIE, the experiences PPIE contributors had within this process, the lessons learned from the experiences, and recommendations for others who may want to do similar work in the future. The work outlined in this paper provided the Mobilise-D consortium with a foundation from which future PPIE tasks can be created and managed with clearly defined collaboration between researchers and patient representatives across Europe. This paper provides guidance on the work required to set up PPIE structures within a large consortium to promote and support the creation of meaningful and efficient PPIE related to the development of digital mobility outcomes.

Indexed as

Digital TechnologyPatient ParticipationEuropeHumansOutcome Assessment, Health CarePatientsdigital mobility measuresdigital mobility outcomespatient engagementpatient involvementpublic-private partnershipreal-world mobilityresearch consortium

Identifiers

PMID37889531
PMCPMC10638632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.